COVA-4231

N/A

Report date: 2026/03/19 16:59:45

Base Information

Drug NameCOVA-4231

Drug Alias NameCOVA-4231

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionMyeloid cell surface antigen CD33 inhibitorsAnti-CD3

TargetsMyeloid cell surface antigen CD33T cell surface glycoprotein CD3

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCovagen Ag

China Registration ClassN/A

Develop Information

Active CompaniesCovagen Ag

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A